Sees FY24 adjusted EBITDA (20M) – $20M.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CLOV:
- Clover Health Reports Fourth Quarter and Full Year 2023 Financial Results; Delivers Continued Momentum in Financial Performance and Provides Full-Year 2024 Guidance
- Options Volatility and Implied Earnings Moves Today, March 12, 2024
- Options Volatility and Implied Earnings Moves This Week, March 11 – March 15, 2024
- Industry Veteran Clay Thornton Joins Clover Health as CFO of Medicare Advantage
- Clover Health to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024